Cartesian Therapeutics Stock (NASDAQ: RNAC)

Dernières nouvelles pour Cartesian Therapeutics (NASDAQ:RNAC) Stock

CARTESIAN THERAPEUTICS INC

Cartesian Therapeutics

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Cartesian Therapeutics, Inc. - Common Stock

Cartesian Therapeutics Inc

Piper Sandler analyst Ryan Todd maintains HF Sinclair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DINO#NYSE">DINO</a>) with a Overweight and raises the price target from $43 to $53.

News

Price Target

Analyst Ratings

DINO

Piper Sandler Maintains Overweight on HF Sinclair, Raises Price Target to $53

WIIM

ACI stock has given up its prior gain. Albertons Companies shares were trading higher following better-than-expected Q1 financial results.

SPEGU

Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

UBS analyst Brent Dilts maintains Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) with a Buy and lowers the price target from $84 to $76.

UBS Maintains Buy on Equity Residential, Lowers Price Target to $76

<a href="https://www.benzinga.com/markets/tech/25/07/46407417/jim-cramer-made-faang-popular-now-he-says-theres-a-new-acronym-to-describe-these-retail-favorite-stocks-parc">Jim Cramer's 2025 &#8216;PARC&#8217; basket</a> &#8211; Palantir Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), Applovin Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>), Robinhood Markets Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) and Coinbase Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) &#8211; is still riding the retail wave.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">A new acronym for the meme stocks that just won't quit!!! PARC! <a href="https://t.co/m3HmDYDxup">pic.twitter.com/m3HmDYDxup</a>
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1944879501931880861?ref_src=twsrc%5Etfw">July 14, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
But one name is breaking away from the meme crowd with real technical muscle: Robinhood.
<h2 class="wp-block-heading">Robinhood's Technical Knockout</h2>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715"><img loading="lazy" decoding="async" width="627" height="485" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15072823/Screenshot-2025-07-15-at-4.37.04-PM.png" alt="" class="wp-image-985737" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15072823/Screenshot-2025-07-15-at-4.37.04-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15072823/Screenshot-2025-07-15-at-4.37.04-PM-300x232.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715">Chart created using Benzinga Pro</a>
Up 153% year-to-date, HOOD is charging toward a major breakout. Trading near $100, the stock boasts an RSI (relative strength index) of 73.13, which is bullish but not overheated, and a MACD (moving average convergence divergence) of 7.72, signaling solid momentum. Importantly, it's riding high above all its key moving averages:
<ul class="wp-block-list">
<li>Eight-day SMA (simple moving average): $96.08</li>
<li>20-day SMA: $87.22</li>
<li>50-day SMA: $72.70</li>
<li>200-day SMA: $47.82</li>
</ul>
A decisive move above $105 could unlock upside toward $120, with strong technical support between $87 and $80. Robinhood's fundamentals are also firing. In the fourth quarter of 2024, crypto became Robinhood&#8217;s top revenue source, generating $358 million in transaction revenue &#8211; a 733% year-over-year increase &#8211; driven by a 455% surge in trading volume. It accounted for over 35% of the company's total net revenue.
Read Also: <a href="https://www.benzinga.com/trading-ideas/technicals/25/06/45951088/robinhood-is-trending-again-is-the-meme%E2%80%91stock-favorite-gearing-up-for-a-breakout">Robinhood Is Trending Again: Is The Meme‑Stock Favorite Gearing Up For A Breakout?</a>
<h2 class="wp-block-heading">PARC Peers: Slowing Momentum</h2>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715"><img loading="lazy" decoding="async" width="627" height="485" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15073957/Screenshot-2025-07-15-at-4.37.17-PM.png" alt="" class="wp-image-985753" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15073957/Screenshot-2025-07-15-at-4.37.17-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15073957/Screenshot-2025-07-15-at-4.37.17-PM-300x232.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715">Chart created using Benzinga Pro</a>
Palantir is up 98% YTD, buoyed by AI-driven government contracts. But its RSI has cooled to 63.84, and it's now hovering just above its eight-day SMA ($142.33), showing signs of consolidation near resistance at $150.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715"><img loading="lazy" decoding="async" width="627" height="485" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074858/Screenshot-2025-07-15-at-4.37.30-PM.png" alt="" class="wp-image-985767" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074858/Screenshot-2025-07-15-at-4.37.30-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15074858/Screenshot-2025-07-15-at-4.37.30-PM-300x232.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715">Chart created using Benzinga Pro</a>
AppLovin is the surprise underperformer—up just 4.1% YTD. While the stock has broken above its eight-day and 20-day SMAs, its RSI at 52.19 shows waning momentum. The ad tech rally looks like yesterday's news.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715"><img loading="lazy" decoding="async" width="627" height="485" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15075003/Screenshot-2025-07-15-at-4.37.41-PM.png" alt="" class="wp-image-985773" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15075003/Screenshot-2025-07-15-at-4.37.41-PM.png 627w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/15075003/Screenshot-2025-07-15-at-4.37.41-PM-300x232.png 300w" sizes="(max-width: 627px) 100vw, 627px" /></a></figure>
<a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0715">Chart created using Benzinga Pro</a>
Coinbase has posted a respectable 53% YTD gain, with a strong MACD of 32.62 and a relatively hot RSI of 74.33. However, it remains highly correlated with Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) swings, lacking the diversified retail driver of Robinhood. While COIN trades above all major moving averages, its setup isn't as clean.
<h2 class="wp-block-heading">Verdict: Robinhood Rules The PARC Pack</h2>
Cramer may have given all four names a shoutout, but Robinhood is stealing the technical spotlight. With momentum, volume and fundamentals aligned, it's the only PARC stock knocking on breakout territory while the rest play catch-up.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46262055/greed-mode-on-why-tesla-nvidia-palantir-and-bitcoin-plays-could-rip">Greed Mode On: Why Tesla, Nvidia, Palantir And Bitcoin Plays Could Rip</a></li>
</ul>
Photo: Shutterstock

Technicals

Tech

Trading Ideas

$BTC

COIN

HOOD

PLTR

Cramer's PARC Playbook: Robinhood's Breakout Potential Outshines The Meme Stock Pack

CYCC

Cyclacel Pharmaceuticals Shares Halted On Circuit Breaker To The Upside, Stock Now Up 348.6%

Cyclacel Pharmaceuticals Shares Resume Trading

Piper Sandler analyst Michael Lavery maintains The Campbell's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPB#NASDAQ">CPB</a>) with a Overweight and lowers the price target from $41 to $35.

Piper Sandler Maintains Overweight on The Campbell's, Lowers Price Target to $35

Albertsons Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) reported better-than-expected first-quarter earnings and sales Tuesday morning, but shares remained relatively flat amid margin pressure <a href="https://www.benzinga.com/pressreleases/25/07/b46411724/albertsons-companies-inc-reports-first-quarter-fiscal-2025-results" target="_blank" rel="noreferrer noopener">and a dip in cash reserves.</a> 
The company registered quarterly adjusted earnings per share of 55 cents, beating the analyst consensus estimate of 53 cents.
Quarterly sales of $24.88 billion (+2.5% year over year) outpaced the street view of $24.716 billion.
Identical sales increased 2.8%, driven by strong growth in pharmacy sales, while digital sales surged 25%, reflecting robust consumer engagement online.
Also Read:<a target="_blank" href="https://www.benzinga.com/news/topics/25/07/46330308/are-you-really-free-if-your-groceries-are-so-expensive-you-cant-afford-them-asks-former-ftc-chair-lina-khan-challenging-corporate-power" rel="noreferrer noopener"> &#8216;Are You Really Free If Your Groceries Are So Expensive You Can&#8217;t Afford Them?&#8217; Asks Former FTC Chair Lina Khan, Challenging Corporate Power</a>
Loyalty program membership grew 14%, reaching 47.3 million members.
Gross margin rate decreased to 27.1% during the first quarter of fiscal 2025 compared to 27.8% during the first quarter of fiscal 2024. Excluding the impact of fuel and LIFO expense, the gross margin rate decreased 85 basis points compared to the first quarter of fiscal 2024.
Net gain on property dispositions and impairment losses was $31.9 million during the quarter, wider than the net loss of $5.3 million in the year-ago period.
Adjusted EBITDA declined to $1.11 billion in Q1 FY25 from $1.18 billion a year earlier. Adjusted EBITDA margin slipped to 4.5% from 4.9% year-over-year.
The company exited the quarter with cash and equivalents of $151 million, significantly lower than the $293.6 million reported on February 22, 2025.
Dividend: On July 15, the company announced the next quarterly dividend payment of $0.15 per share, payable on August 8, 2025, to stockholders of record as of the close of business on July 25, 2025.
Outlook: Albertsons reaffirmed its FY25 adjusted EPS outlook of $2.03–$2.16, in line with estimates. It raised its identical sales growth forecast to 2%–2.75% from the prior 1.5%–2.5% range.
&#8220;As we look forward to the balance of fiscal 2025, we do so with continued confidence in our Customers for Life strategy,&#8221; said CEO Susan Morris. 
In a separate presentation, the company stated that it will <a href="https://s29.q4cdn.com/239956855/files/doc_financials/2025/q1/17821_corpcomm25_q1_infographic.pdf" target="_blank" rel="noopener">deliver</a> $1.5 billion in savings over FY25-FY27.
Price Action: ACI shares are trading higher by 0.09% to $22.15 premarket at last check on Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/large-cap/25/07/46413056/tapestry-ups-investment-in-recycled-leather-pioneer-gen-phoenix" target="_blank" rel="noreferrer noopener">Coach Parent Tapestry Ups Investment In Recycled Leather Pioneer Gen Phoenix</a></li>
</ul>
Photo: Shutterstock

Earnings

Movers

Albertsons Profit Falls In Q2, Sets $1.5 Billion Savings Goal

BTCT

BTC Digital shares are trading lower after the company announced a $6 million registered direct offering of 2 million shares at $3.00 per share.

Bank of New York Mellon Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) on Tuesday reported better-than-expected <a target="_blank" href="https://www.benzinga.com/pressreleases/25/07/n46410862/bny-reports-second-quarter-2025-results" rel="noreferrer noopener">second-quarter 2025 results</a>, topping both revenue and earnings estimates.
The firm reported second-quarter adjusted earnings of $1.94 per share, up 28% from a year ago and above <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">the Street estimate of $1.76</a>.
Revenue rose 9% year over year (YoY) to $5.03 billion, topping analysts&#8217; forecast of $4.83 billion.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/07/46275838/bank-of-new-york-mellon-likely-to-report-higher-q2-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call" rel="noreferrer noopener">Bank of New York Mellon Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>
Fee revenue in the quarter grew 7% YoY to $3.641 billion. Net interest income rose 17% YoY, driven by higher-yield reinvestments and balance sheet growth, partly offset by deposit mix shifts.
Noninterest expense rose 4%, driven by higher investments, wage increases, FDIC adjustments, and a weaker dollar, partly offset by efficiency gains.
Provision for credit losses was a $17 million benefit, mainly due to reserve releases tied to commercial real estate exposure.
Assets under custody and/or administration rose 13%, driven by client inflows, higher market values, and a weaker U.S. dollar. Assets under management increased 3% as market gains and favorable currency impact offset cumulative net outflows.
The average deposit totaled $300 billion, up 5% year over year and 6% from the prior quarter. The Tier 1 leverage ratio rose 23 basis points yearly to 6.1%.
BNY returned $1.2 billion to common shareholders year-to-date, including $346 million in dividends and $895 million in share repurchases, resulting in a total payout ratio of 92%.
CET1 capital rose to $20.1 billion and Tier 1 capital to $25.5 billion as of June 30, 2025, driven by earnings and gains in other comprehensive income, partly offset by buybacks and dividends.
The CET1 ratio held steady at 11.5%, as increased risk-weighted assets offset higher capital, while the Tier 1 leverage ratio dipped to 6.1% due to higher average assets.
Liquidity and funding remained strong, with an average liquidity coverage ratio (LCR) of 112% and NSFR of 131%. TLAC ratios stayed above regulatory minimums.
BNY declared a quarterly <a href="https://www.benzinga.com/pressreleases/25/07/n46410867/bny-declares-dividends" target="_blank" rel="noreferrer noopener">dividend</a> of 53 cents per share, up from 47 cents. The dividend is payable on Aug. 7, 2025, to shareholders of record as of July 25, 2025.
&#8220;BNY&#8217;s ongoing transformation has significant momentum. Only one year after the launch of our new commercial model last summer, we delivered two consecutive quarters of record sales in the first half of the year. It is also notable that the parts of the company that were the first to transition to our platform&#8217;s operating model in the spring of last year have displayed faster delivery times, enhanced service quality, increased innovation along with greater efficiency,&#8221; commented Robin Vince, CEO.
Vince mentioned that the firm reported significant positive operating leverage, driving a pre-tax margin of 37% and a return on tangible common equity (ROTCE) of 28%.
<h2 class="wp-block-heading">Outlook</h2>
BNY <a target="_blank" href="https://www.bny.com/assets/corporate/documents/pdf/investor-relations/earnings/quarterly-update-presentation-2q-2025.pdf" rel="noreferrer noopener">updated</a> its 2025 financial outlook, reflecting stronger first-half results and revised market-implied interest rates as of June 30.
Net Interest Income is expected to grow in the high single digits year over year, with expenses up around 3%, resulting in positive operating leverage.
Price Action: BK shares were trading higher by 0.01% to $95.26 at last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/earnings/25/07/46412039/blackrocks-aum-jumps-to-12-53-trillion-revenue-up-13" target="_blank" rel="noreferrer noopener">BlackRock&#8217;s Q2 Net Inflows, Performance Fees Take A Hit</a></li>
</ul>
Photo by JHVEPhoto via Shutterstock

Guidance

BNY Mellon's Strong Q2 Profit Drives Higher 2025 Guidance

WFC stock has given up its prior gain. Wells Fargo shares were trading higher after the company reported better-than-expected Q2 adjusted EPS results.

Shares of Applied Materials Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) are gaining Tuesday, swept up in a broad rally across the artificial intelligence chip sector. The positive momentum is being driven by two developments pointing toward increased demand for semiconductors and the equipment needed to produce them.
What To Know: A primary catalyst was news of the Trump administration&#8217;s plan to unveil a <a href="https://www.benzinga.com/markets/tech/25/07/46412125/trumps-latest-move-on-ai-and-china-propels-chip-stocks">$70 billion investment</a> initiative in Pennsylvania focused on AI and energy. The proposal includes building new data centers and upgrading power grids, signaling a massive expansion in infrastructure that will require a substantial volume of new chips. 
As a leading supplier of semiconductor manufacturing equipment, Applied Materials is directly positioned to benefit from chipmakers like TSMC and Micron ramping up production to meet this demand.
Further fueling the optimism was the U.S. government's decision to ease certain <a href="https://www.benzinga.com/trading-ideas/movers/25/07/46413630/chinese-stocks-see-broad-rally-as-us-eases-chip-curbs">export restrictions</a> on advanced AI chips to China. This policy shift is expected to reopen a major market for companies such as Nvidia, which had previously been barred from selling its high-end products there. 
The potential for renewed sales to China would drive global chip production higher, potentially increasing the need for AMAT's fabrication systems and services.
Benzinga Edge Rankings: According to recent <a href="https://www.benzinga.com/quote/AMAT/analyst-ratings">analyst data</a> from Benzinga, Wall Street has shown largely positive sentiment towards Applied Materials in July. 
On July 10, Goldman Sachs initiated coverage on the stock with a strong Buy rating and a $225 price target. This bullishness was echoed by several other firms, including Mizuho, Wells Fargo and Citigroup, which all maintained their buy-equivalent ratings while increasing their price targets to $220, $215 and $220, respectively. 
However, the view is not unanimously positive. On July 7, Redburn Atlantic issued a downgrade from Buy to Neutral, lowering its price target to $200. Morgan Stanley also maintains a more cautious Equal-Weight rating, despite a modest price target increase at the beginning of the month.
Price Action: According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, AMAT shares are trading higher by 1.67% to $200.45 Tuesday morning. The stock has a 52-week high of $248.81 and a 52-week low of $123.74.
Read Also: <a href="https://www.benzinga.com/markets/tech/25/07/46367170/why-lam-research-outpaced-market-with-40-gain-in-2025">Why Lam Research Outpaced Market With 40% Gain In 2025</a>
<h2 class="wp-block-heading">How To Buy AMAT Stock</h2>
By now you're likely curious about how to participate in the market for Applied Materials &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
In the case of Applied Materials, which is trading at $200.45 as of publishing time, $100 would buy you 0.5 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
Image: Shutterstock

AMAT

Applied Materials (AMAT) Stock Is Rising: What's Going On?

<a href="https://www.bloomberg.com/news/articles/2025-07-15/stellantis-backs-out-of-hydrogen-venture-with-michelin-forvia" title="https://www.bloomberg.com/news/articles/2025-07-15/stellantis-backs-out-of-hydrogen-venture-with-michelin-forvia">https://www.bloomberg.com/news/articles/2025-07-15/stellantis-backs-out-of-hydrogen-venture-with-michelin-forvia</a>

STLA

'Stellantis to Halt Investments in Hydrogen Joint Venture' - Bloomberg News

UBS analyst Michael Goldsmith maintains Camden Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPT#NYSE">CPT</a>) with a Neutral and lowers the price target from $126 to $114.

UBS Maintains Neutral on Camden Prop Trust, Lowers Price Target to $114

<a href="https://www.bloomberg.com/news/articles/2025-07-15/spacex-said-to-plan-starship-program-for-in-orbit-drug-research" title="https://www.bloomberg.com/news/articles/2025-07-15/spacex-said-to-plan-starship-program-for-in-orbit-drug-research">https://www.bloomberg.com/news/articles/2025-07-15/spacex-said-to-plan-starship-program-for-in-orbit-drug-research</a>

DXYZ

'SpaceX Plans Starship Program for In-Orbit Drug Research' - Bloomberg News

Piper Sandler analyst Patrick Moley maintains Virtu Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIRT#NYSE">VIRT</a>) with a Overweight and raises the price target from $44 to $48.

VIRT

Piper Sandler Maintains Overweight on Virtu Finl, Raises Price Target to $48

Monolithic Power Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>) has outperformed the market over the past 15 years by 15.56% on an annualized basis producing an average annual return of 28.06%. Currently, Monolithic Power Systems has a market capitalization of $35.18 billion. 
Buying $1000 In MPWR: If an investor had bought $1000 of MPWR stock 15 years ago, it would be worth $40,202.10 today based on a price of $721.14 for MPWR at the time of writing.
<h3>Monolithic Power Systems's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752589814_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MPWR

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

Joby Aviation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) stock is trading higher Tuesday after the company announced that it&#8217;s expanding its manufacturing capacity at its facilities in California and Ohio and adding aircraft <a href="https://www.benzinga.com/node/46414345">to its fleet</a>.
What To Know: Joby said its Marina, California site now spans approximately 435,500 square feet, doubling its production capacity. The company also ramped up its newly renovated facility in Dayton, Ohio to manufacture and test aircraft components.
The expansion supports Joby&#8217;s plans to scale commercial operations. The Marina site is expected to produce up to 24 aircraft per year and house key functions including FAA production certification, flight testing, pilot training, and maintenance.
&#8220;We celebrated the opening of the new facility with the flight of our sixth aircraft, which earned airworthiness certification within a week of completion,&#8221; said Eric Allison, Chief Product Officer. &#8220;Our expanded manufacturing footprint in both California and Ohio is preparing us to scale with speed and precision.&#8221;
The company is leveraging Toyota's manufacturing expertise to drive efficiency and scale. It plans to eventually build up to 500 aircraft annually at the Dayton location.
See Also: <a href="https://www.benzinga.com/markets/equities/25/07/46415275/nutanix-stock-looks-bullish-but-a-peak-could-be-forming">Nutanix Stock Looks Bullish, But A Peak Could Be Forming</a>
JOBY Price Action: At the time of writing, Joby shares are trading 5.29% higher at $13.30, according to data from <a href="https://pro.benzinga.com/">Benzinga Pro.</a>
Image: Courtesy of Joby Aviation

JOBY

Joby Stock Is Moving Higher Tuesday: What's Going On?

Piper Sandler analyst Patrick Moley maintains Tradeweb Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TW#NASDAQ">TW</a>) with a Neutral and raises the price target from $127 to $130.

Piper Sandler Maintains Neutral on Tradeweb Markets, Raises Price Target to $130

Press Releases

Cartesian Therapeutics Announces New Employment Inducement Grant

Cartesian Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update

Cartesian Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics' Descartes-08 Observed to Provide Deep and Sustained Benefits Through Month 12 After a Single Course of Therapy in Phase 2b Myasthenia Gravis Trial

Comments

Cartesian Therapeutics

Actualités

Dernières nouvelles pour Cartesian Therapeutics (NASDAQ:RNAC) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL